Rhenman & Partners Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31M | Sell |
33,715
-8,505
| -20% | -$8.62M | 3.83% | 3 |
|
|
2025
Q4 | $45.4M | Sell |
42,220
-11,200
| -21% | -$10.7M | 4.24% | 2 |
|
|
2025
Q3 | $40.8M | Sell |
53,420
-4,450
| -8% | -$3.31M | 4.51% | 2 |
|
|
2025
Q2 | $45.1M | Buy |
57,870
+16,120
| +39% | +$12.5M | 5.7% | 1 |
|
|
2025
Q1 | $34.5M | Sell |
41,750
-3,700
| -8% | -$3.08M | 3.96% | 2 |
|
|
2024
Q4 | $35.1M | Sell |
45,450
-2,050
| -4% | -$1.7M | 3.61% | 2 |
|
|
2024
Q3 | $42.1M | Buy |
47,500
+500
| +1% | +$450K | 3.42% | 3 |
|
|
2024
Q2 | $42.6M | Sell |
47,000
-7,175
| -13% | -$5.74M | 4.09% | 4 |
|
|
2024
Q1 | $42.1M | Sell |
54,175
-23,830
| -31% | -$17M | 3.99% | 2 |
|
|
2023
Q4 | $45.5M | Sell |
78,005
-21,995
| -22% | -$12.8M | 4.54% | 2 |
|
|
2023
Q3 | $53.7M | Buy |
100,000
+19,000
| +23% | +$9.79M | 5.79% | 1 |
|
|
2023
Q2 | $38M | Buy |
+81,000
| New | +$34M | 4% | 1 |
|
|
2023
Q1 | – | Sell |
-88,000
| Closed | -$32.2M | – | 91 |
|
|
2022
Q4 | $32.2M | Sell |
88,000
-9,000
| -9% | -$3.19M | 3.36% | 1 |
|
|
2022
Q3 | $35.1M | Buy |
97,000
+7,000
| +8% | +$2.22M | 3.68% | 1 |
|
|
2022
Q2 | $29.2M | Sell |
90,000
-33,500
| -27% | -$10.1M | 3.32% | 2 |
|
|
2022
Q1 | $35.4M | Sell |
123,500
-46,500
| -27% | -$12M | 3.49% | 1 |
|
|
2021
Q4 | $47.1M | Buy |
170,000
+25,000
| +17% | +$6.34M | 3.13% | 3 |
|
|
2021
Q3 | $33.5M | Buy |
145,000
+26,200
| +22% | +$6.47M | 2.35% | 12 |
|
|
2021
Q2 | $27.3M | Sell |
118,800
-51,200
| -30% | -$10.3M | 1.85% | 13 |
|
|
2021
Q1 | $31.8M | Sell |
170,000
-10,000
| -6% | -$1.96M | 2.21% | 13 |
|
|
2020
Q4 | $30.4M | Buy |
180,000
+15,000
| +9% | +$2.24M | 2.48% | 7 |
|
|
2020
Q3 | $24.4M | Buy |
165,000
+60,000
| +57% | +$9.29M | 2.17% | 12 |
|
|
2020
Q2 | $17.2M | Buy |
105,000
+5,000
| +5% | +$767K | 1.86% | 15 |
|
|
2020
Q1 | $13.9M | Sell |
100,000
-11,446
| -10% | -$1.57M | 1.94% | 16 |
|
|
2019
Q4 | $14.6M | Sell |
111,446
-38,554
| -26% | -$4.47M | 1.61% | 24 |
|
|
2019
Q3 | $16.8M | Sell |
150,000
-10,000
| -6% | -$1.11M | 2.1% | 15 |
|
|
2019
Q2 | $17.7M | Buy |
160,000
+61,305
| +62% | +$7.22M | 1.95% | 20 |
|
|
2019
Q1 | $12.8M | Sell |
98,695
-25,000
| -20% | -$3.04M | 1.5% | 25 |
|
|
2018
Q4 | $14.3M | Sell |
123,695
-46,305
| -27% | -$5.17M | 1.64% | 26 |
|
|
2018
Q3 | $18.2M | Sell |
170,000
-30,000
| -15% | -$3M | 1.83% | 21 |
|
|
2018
Q2 | $17.1M | Sell |
200,000
-22,859
| -10% | -$1.88M | 1.75% | 24 |
|
|
2018
Q1 | $17.2M | Buy |
222,859
+80,000
| +56% | +$6.44M | 2.13% | 16 |
|
|
2017
Q4 | $12.1M | Buy |
142,859
+32,859
| +30% | +$2.8M | 1.63% | 24 |
|
|
2017
Q3 | $9.41M | Sell |
110,000
-40,000
| -27% | -$3.28M | 1.2% | 33 |
|
|
2017
Q2 | $12.3M | Sell |
150,000
-20,000
| -12% | -$1.63M | 1.77% | 20 |
|
|
2017
Q1 | $14.3M | Sell |
170,000
-45,000
| -21% | -$3.6M | 2.26% | 10 |
|
|
2016
Q4 | $15.8M | Sell |
215,000
-40,000
| -16% | -$2.98M | 3.03% | 4 |
|
|
2016
Q3 | $20.5M | Buy |
255,000
+20,000
| +9% | +$1.6M | 3.25% | 2 |
|
|
2016
Q2 | $18.5M | Buy |
235,000
+40,000
| +21% | +$3.01M | 3.29% | 5 |
|
|
2016
Q1 | $14M | Buy |
195,000
+49,000
| +34% | +$3.71M | 2.79% | 5 |
|
|
2015
Q4 | $12.3M | Sell |
146,000
-39,000
| -21% | -$3.24M | 1.86% | 17 |
|
|
2015
Q3 | $15.5M | Buy |
185,000
+10,000
| +6% | +$844K | 2.47% | 5 |
|
|
2015
Q2 | $14.6M | Buy |
175,000
+46,000
| +36% | +$3.51M | 1.75% | 15 |
|
|
2015
Q1 | $9.37M | Buy |
129,000
+63,000
| +95% | +$4.49M | 1.58% | 21 |
|
|
2014
Q4 | $4.55M | Buy |
66,000
+36,000
| +120% | +$2.43M | 1.32% | 25 |
|
|
2014
Q3 | $1.95M | Sell |
30,000
-14,500
| -33% | -$918K | 0.57% | 74 |
|
|
2014
Q2 | $2.77M | Sell |
44,500
-8,958
| -17% | -$534K | 0.82% | 44 |
|
|
2014
Q1 | $3.15M | Buy |
53,458
+18,458
| +53% | +$1.03M | 0.94% | 39 |
|
|
2013
Q4 | $1.78M | Buy |
+35,000
| New | +$1.75M | 0.7% | 61 |
|
Other funds holding LLY
VCM
VPM
Rhenman & Partners Asset Management's LLY Position: Q1 2026 in Review
Rhenman & Partners Asset Management reduced its Eli Lilly (LLY) stake by 20% in Q1 2026, selling an estimated $8.62M and leaving 33,715 shares worth $31M. The position accounts for 3.83% of the portfolio, ranked #3.
Rhenman & Partners Asset Management first reported a position in LLY in Q4 2013 and has held it in 49 quarters since. The position peaked at $53.7M in Q3 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Rhenman & Partners Asset Management held 33,715 shares of Eli Lilly worth $31M as of Q1 2026.
- Rhenman & Partners Asset Management sold 8,505 Eli Lilly shares in Q1 2026, an estimated $8.62M.
- Eli Lilly made up 3.83% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #3 holding.
- Rhenman & Partners Asset Management first reported a position in Eli Lilly in Q4 2013 and has held it in 49 quarters since.
- Rhenman & Partners Asset Management's Eli Lilly position peaked at $53.7M in Q3 2023.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.